---
figid: PMC8284588__PRO-30-1535-g002
figtitle: Structural perspective on targeting the RTK/Ras/MAP kinase pathway in cancer
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC8284588
filename: PRO-30-1535-g002.jpg
figlink: /pmc/articles/PMC8284588/figure/pro4125-fig-0007/
number: F1
caption: Chemical structures of selected EGFR inhibitors
papertitle: A structural perspective on targeting the RTK/Ras/MAP kinase pathway in
  cancer.
reftext: David E. Heppner, et al. Protein Sci. 2021 Aug;30(8):1535-1553.
year: '2021'
doi: 10.1002/pro.4125
journal_title: 'Protein Science : A Publication of the Protein Society'
journal_nlm_ta: Protein Sci
publisher_name: John Wiley & Sons, Inc.
keywords: cancer biology | drug discovery | kinase | structural biology
automl_pathway: 0.5155541
figid_alias: PMC8284588__F1
figtype: Figure
redirect_from: /figures/PMC8284588__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8284588__PRO-30-1535-g002.html
  '@type': Dataset
  description: Chemical structures of selected EGFR inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gefitinib
  - Lapatinib
  - Erlotinib
  - JBJ-04-125-02
  - Afatinib
  - Osimertinib
  - DDC4002
---
